Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China · Delayed Price · Currency is CNY 22.03
+0.25 (1.15%)
Sep 18, 2026, 3:00 PM CST
SHA:600196 Market Cap
SHA:600196 has a market cap or net worth of 54.24 billion as of September 18, 2026. Its market cap has decreased by -32.53% in one year.
Market Cap
54.24B
Enterprise Value
91.97B
Revenue
42.59B
Ranking
n/a
PE Ratio
17.21
Stock Price
22.03
ChartMarket Cap Chart
Since August 9, 2005, SHA:600196's market cap has increased from 4.38B to 54.24B, an increase of 1,139.36%. That is a compound annual growth rate of 12.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 54.24B | -16.68% |
| Dec 31, 2025 | 65.10B | 8.95% |
| Dec 31, 2024 | 59.75B | -2.99% |
| Dec 29, 2023 | 61.59B | -29.14% |
| Dec 30, 2022 | 86.92B | -23.66% |
| Dec 31, 2021 | 113.86B | -9.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sichuan Biokin Pharmaceutical | 102.79B |
| Yunnan Baiyao Group Co.,Ltd | 91.09B |
| Zhejiang NHU Company | 80.77B |
| Huadong Medicine | 45.77B |
| China Resources Sanjiu Medical & Pharmaceutical | 39.28B |
| Shenzhen Salubris Pharmaceuticals | 33.69B |
| Beijing Tongrentang | 31.85B |
| Humanwell Healthcare (Group) | 30.13B |